cardiotoxicity

Advertisement
Kerri FitzgeraldBreast Cancer News | March 26, 2025
Obese patients with breast cancer who are receiving anthracyclines and/or trastuzumab have an increased risk of ...
DocWire News EditorsCardiology | November 10, 2019
This week's Round-up features two interesting studies focusing on women's health, an interesting cardio-oncology paper, ...
Rob DillardCardiology | November 6, 2019
Research published in JACC CardioOncology suggests that neurohormonal therapies are associated with higher left ...
Kerri FitzgeraldCardiology | October 8, 2019
Physical exercise may be a promising and effective treatment for patients with cancer during and after chemotherapy in ...
DocWire News EditorsCardiology | April 12, 2023
Ibrutinib administration was associated with a number of severe cardiac events, results from a new analysis suggest. ...
Rob DillardCardiology | June 30, 2023
Many patients with cancer undergoing treatment incur a risk of cardiotoxicity, and these patients are not being made ...
DocWire News EditorsInterventional Cardiology | May 2, 2023
This week’s edition of the Cardio Round-up includes a warning about skipping breakfast, an FDA approval on the ...
Kerri FitzgeraldOncology | April 26, 2019
Here are the top stories covered by DocWire News this week in the Hematology/Oncology section. This week the U.S. Food ...
DocWire News EditorsCardiology | April 24, 2019
A new paper in Cardiovascular Research looks at genomic predisposition to oncology-drug-induced cardiotoxicity, which ...
DocWire News EditorsCardiology | February 5, 2019
New research published in JAMA Oncology suggests that daunorubicin is associated with lower incidence of cardiomyopathy ...
Advertisement